INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 57 filers reported holding INSTIL BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,343,000 | +112.0% | 897,386 | +102.3% | 0.40% | +107.7% |
| Q2 2022 | $2,049,000 | -75.0% | 443,562 | -41.8% | 0.19% | -66.7% |
| Q1 2022 | $8,196,000 | -32.8% | 762,388 | +6.9% | 0.58% | -24.5% |
| Q4 2021 | $12,203,000 | +0.5% | 713,221 | +5.0% | 0.77% | -12.9% |
| Q3 2021 | $12,140,000 | -26.3% | 679,171 | -20.4% | 0.89% | -14.2% |
| Q2 2021 | $16,476,000 | +19.5% | 852,819 | +55.2% | 1.03% | +7.5% |
| Q1 2021 | $13,784,000 | – | 549,587 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $16,255,471 | 100.00% |
| CPMG Inc | 8,218,467 | $3,517,504 | 1.92% |
| Western Standard LLC | 1,796,987 | $769,110 | 0.70% |
| Vivo Capital, LLC | 12,486,787 | $5,344,345 | 0.59% |
| Nantahala Capital Management | 1,000,000 | $428,000 | 0.04% |
| Baker Brothers Advisors | 4,704,395 | $2,013,481 | 0.01% |
| HCR Wealth Advisors | 40,000 | $17,120 | 0.00% |
| Hennion & Walsh Asset Management, Inc. | 98,080 | $41,978 | 0.00% |
| Long Focus Capital Management, LLC | 100,000 | $42,800 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 867,279 | $371,195 | 0.00% |